Bio-Extraction(TSX.V: V.BXI) -Nahrungsmittelunternehmen in Nischenmarkt (Seite 5)
neuester Beitrag 09.09.12 19:33:45 von
der Link zur Meldung auf die Homepage funktioniert bei mir gerade nicht(?) -wahrscheinliche Vorverlegung der Isolate Produktion(voraussichtlich erstmal halbe Kapazität der Isolate) noch dieses Jahr!!!! Sollte eigentlich für einen Schub sorgen. Wenn das auch so aufgeht(mit mit solchen Sachen inzwischen ziemlich vorsichtig geworden) ist das eine Knallermeldung. Sie wollen das Geld wohl möglichst auf "non-dilutive" Wege besorgen, aber eventl. könnte dadurch noch ein PP Thema werden, kann ich jetzt aus dem Stand nicht abschätzen. Damit soll v.a. auch die 2te Anlage schneller angeschoben werden. Den GRAS Status gibt´s wahrscheinlich auch bis Ende des Jahres, die noch ausstehenden Zertifizierungen für Kanada wohl auch:
BioExx Announces Plan to Advance Protein Isolate Production to 2009 - Baystreet - 6/23/2009
- Highlights - Isolate production can be accelerated to late 2009 from early 2011 - Isolates to be incorporated into single system capable of full range of proteins - Earlier implementation of Isolates would enhance margins and reduce operating risk - GRAS, HACCP, GMP Plus, and ISO 22000 all expected by year-end -
"TORONTO, ONTARIO -- Bio-Extraction Inc. (TSX VENTURE: BXI) ("BioExx" or "the Company") is pleased to announce that it has developed a plan to commence production and sales of its high-value Protein Isolate and Hydrolyzed Protein products (together "Protein Isolates") before the end of 2009. Originally, BioExx had planned to reach this very significant milestone in early 2011. The advanced schedule, which does require additional equipment, flows from the enhancements to the design of its extraction process as announced on April 22, combined with continued progress with regulatory certifications and strong market demand.
The planned system builds upon the existing design utilizing provisional patent applications in the United States (and subsequent PCT applications) for both its Protein and Extraction processes, and will now allow for the production of all grades of proteins from one integrated process. The key additional equipment in the new BioExx protein system is well proven in a broad range of food processing applications, including the production of whey, soy, and pea proteins.
The original plan to commence Isolate production in early 2011 involved a significant additional expenditure to build what was essentially a separate process added to the initial lower-value Protein Concentrate plant. The accelerated Isolate producing process will require that additional planned capital expenditures be made earlier, but will avoid the redundancy of some equipment that would have occurred by installing the systems in separate phases. To fund the accelerated process, the Company intends to access a combination of proceeds from the exercise of outstanding share purchase warrants which expire in January 2010, and other non-dilutive sources of capital that may be available. To achieve the goal of producing Isolates by the end of 2009, BioExx will seek the cooperation of warrant holders to exercise their warrants on a steady basis between now and expiry. If the warrants are exercised at a slower pace than desired, the accelerated start-up date could shift commensurately to as late as June 2010.
"Despite the many prior accomplishments by BioExx, we believe this is the most significant milestone achieved to date," said BioExx CEO Chris Carl. "The production and sale of high-value proteins has always been our end goal and the key driver of shareholder value in this business. To be able to reach the Isolate production goal much earlier than planned, and in a manner which can deliver enhanced upside while at the same time mitigating risk, is an accomplishment of which we are very proud."
To smooth the implementation and scale-up of Isolate production, BioExx will initially install a system which will run at approximately half of target Isolate capacity. As production and cash flow grows, additional equipment will be added to increase capacity to full plan. This approach is expected to facilitate production volumes which are in line with typical ramp-up rates while at the same time deferring and reducing at-risk capital.
The Company believes that in addition to driving higher revenues and margins by entering its higher-value protein markets earlier, this accelerated plan has several risk mitigation benefits that include:
- The protein system to be deployed would be capable of producing the entire range of specialty proteins, versus an implementation capable of producing only lower-end Protein Concentrates;
- Converting from a Concentrate-only system would require additional equipment and processes for Isolates, some of which would be redundant, and while this was originally thought unavoidable, it is not acceptable in the presence of a demonstrated ability to implement an integrated system capable of producing both products;
- An accelerated deployment of the Isolate system provides for an extra year's experience in Isolate production and sales which is a key benefit for the much larger second facility which would then be able to commence production of Isolates at start-up;
- Successful implementation should result in enhanced cash flow on an earlier schedule, through the production and sale of high margin Isolates, which typically sell for about $6,000 per metric tonne versus Concentrates at $1,000 per metric tonne, and which should result in better access to, and a lower cost of, capital for funding of the second plant.
To enable food-grade specialty protein sales in the United States, BioExx will require GRAS (Generally Regarded As Safe) status. GRAS is a self-affirmed food safety designation which is administered by independent third parties in accordance with the regulations of the US Food and Drug Administration. Based on efforts to date, BioExx expects to self-affirm its GRAS status before the end of 2009, which would allow it to commence the sale of Isolates. In the event that this designation is unexpectedly delayed, the integrated nature of the BioExx protein system will still allow BioExx to produce and sell Protein Concentrate products for markets that do not require GRAS, such as specialty feeds.
The Saskatoon plant will also need to have demonstrated that it has implemented and maintained its procedures in a manner that complies with HACCP, GMP Plus, and ISO 22000. Certification for all of these processes with respect to Phase 1 operations is well advanced and nearing completion. BioExx expects to complete preliminary work with respect to Protein production prior to the planned start-up later this year.
Specialized protein markets are very strong and are widely expected to continue to grow over the long term, driven simply by demand fundamentals exceeding supply. BioExx continues to receive very strong interest in all of its proteins products, with considerable emphasis on Isolates, from around the globe. By working through its primary distributor and in some cases directly, BioExx is excited to be able to offer a solution that will enable these customers to be serviced considerably earlier than originally anticipated.
About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx' patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx' low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE: BXI), please visit www.bioexx.com .
" (...) As a heads up, it looks like Plant #2 may be in North Dakota. BXI hosted an analyst tour last week and apparently there was a delegation of 8 people from various levels of state and municipal government as well as state and local bankers from North Dakota on the tour. I haven't seen that posted anywhere on here yet, but it was in a Wellington West research piece from last week.
Should be fun tomorrow..
Sollte sich das Vorziehen der Phase3 tatsächlich dermassen vorziehen lassen, dann wird das hier noch sehr angenehm. Die primäre Frage dabei scheint mir zu sein, in wiefern sie das nötige Kapital dafür wirklich durch besagte "non-dilutive sources" aufbringen können -der Fall könnte eine potentielle Hebelwirkung dann aber nochmal merklich antreiben.
Auch wenn es nach Pusherei aussehen sollte, stell ich das mal rein:
""I have seen a couple of analysts reports in the past couple of days and boy is it fun to daydream...
Canaccord analyst says greater than $2.00 per share in EPS in five years is possible. Wellington Analyst (which raised their target to $1.70) ran some metrics for plant 2... wow..
Plant #1 can do 30MM in EBITDA at 100% run rate on the Isolates
Plant #2 can do $65MM in EBITDA at 100% run rate on the isolates
That is $95MM in EBITDA possible by 2011 on probably 170-190MM shares outstanding.. somewhere in the range of $0.55/share in EBITDA with massive growth (3 more plants and licensing agreements) ahead.. what sort of multiple do you think that would attract...
All of this is however contingent on Phase 2 and 3 working. The nice thing is that Phase 3 looks much lower risk than previously thought as they are using proven equipment and technology. That leaves the Phase 2 extraction as the big wild card. What is great about the new timeline on the isolates is that we will find out within about 6 months whether this is going to all come together
I have said it before and I will say it again... this is the best looking small-cap company I have seen. This could be a major homerun in the making.
Of course, I have done my DD and you should do yours... Don't rely on this board, analysts reports or anything other than your own homework.
Achso, größeres Thema in den kanadischen Stockboards war noch, wie man die Warrantholder denn zu einem vorzeitigen einlösen animieren könnte. Der Tenor ging dann dahin, dass Denen das wahrs. mit ein paar kleinen Vorzügen versüsst wird. Hoffe, dass die nicht zu süss ausfallen, aber das scheint mir doch Sinn zu machen &recht wahrscheinlich(zumindest der Versuch in die Richtung).
"Hello everyone, I have a big position on BXI from 45 cents (over 200,000) and I did some DD today.
The info gathered is from someone in "the know" that I trust and I had to know whether to hold or sell my shares for profit . Conclusion - HOLD until $ 5.00 within 2 years WHY ?
1. The management are honest, hard working and are actually minimizing the huge potential of their patented methodology
2. MCN and Burcon have inferior separation methods and are higher cost
3. Burcon already has GRAS for canola protein isolates and BXI GRAS is imminent
4. Canola commodity price is hedged and protein isolates sales and prices quaranteed and highly needed
5. The warrants will all be exercised by expiry Jan 2010 as most are held by institutions and already pledged to the company so that the cash will be there for all equipment purchases
6. The high recent volume is from the 65 % insitutional investors who "have been sold" on the execution capabilty of the mangement
7. Current production and sales is "massive "and will be cash flow positive by Q4 2009 and ther eis sufficient capital from non=dilutive sources to pay for the new equipment
8. Orders for the equipment is in and delivery immminent
9. PEI research facilities have moved to Saskatoon - new plant being planned by engineers
10. No new shares will need to be issued as cash flow is increasing exponentially
11. Major world food companies are interested in these BXI patents which have successfully shown and proven the laboratory and pilot protein isolates procedure to be commercially cost effective
12. 40,000 MT to 80 to 160 to 240,000 MT may also accelerated
13. No reverse split needed as stock should be over $ 5 in ONE YEAR
14. Bay street expects this BXI to be off venture and on the TSX in due course
Follow the money and trade houses
Bye fro now and good luck to all the patient longs who were in 2007 at .30 cents and 2008 at .40 cents
Managment has made good on all their executive plans they work hard and are diligent
- By Joanne Paulson -
"Things are going swimmingly at the BioExx plant in the North Corman Industrial Park just outside Saskatoon.
The company poised to produce fish and baby livestock feed from canola, and already crushing oil, will also ramp up production of high-value proteins before the end of the year. That's at least one year earlier than the company anticipated. The plant just opened in March.
"There are several grades of protein that can be derived from canola, and the highest grade is something called protein isolate," explained CEO Chris Carl in an interview this week from Toronto.
Isolates can be used in high-value foods such as baby formula, nutrition bars and energy drinks.
"We did not expect to be making these isolates until 2011," said Carl. "With some design changes that our engineers and POS (Pilot Plant) have been working on, we have advanced that to the point where we think we'll be making and selling isolates before the end of this year.
- Laurence Parslow, director of research and development with BioExx; the company plans to spend millions at its North Corman Industrial Park plant to produce high-value proteins from canola -
"The value of all of this has gone up rather dramatically. We do process the seed, we take the oil out, we will still produce an animal feed-based meal, but we will now produce an entire range of specialty protein products including the very high protein isolate before the end of 2009."
Indeed, BioExx (formally Bio-Extraction Inc.) wasn't sure it could make the protein isolates -- yet. A discovery made just in the last few weeks pointed the company in a new direction.
"As often is the case in new technology, we set out to solve one concern (in the extraction process) that we had," said Carl. "In solving that, we accidentally created an opportunity to make our isolates more quickly using standardized equipment in a design we already were working with."
With the ramped-up deadline, BioExx will spend more money at the Saskatoon plant this year than originally planned.
"We'll be spending several million dollars more than anticipated this year. The construction activity will begin in earnest again over the next couple of months," said Carl.
"We will be doing some more hiring at the site. We'll probably hire at least another eight people over what we had anticipated, bringing employees at the plant in excess of 30 people."
BioExx uses proprietary low-temperature extraction, employing temperatures under 60 Celsius. After that threshold of heat, the solubility of the protein starts to be affected or "denatured," said Carl.
The unique process doesn't make the protein better, or increase the amount, but it makes the protein far more "bioavailable" for absorption in the body.
Canola is also an excellent source of vegetable protein in the first place.
"Protein that comes from canola has double the protein efficiency ratio of the protein that comes out of soy," said Carl. "Canola proteins tend to have much higher nutritional value than other vegetable proteins."
Carl said it's too early to estimate the ultimate annual value of the proteins and oils coming out of the Saskatoon plant. However, for context, he noted the plant will process 40,000 tonnes of canola seed annually, at market price -- which today is about $450 per tonne.
"We can make a pretty healthy margin once we are selling our proteins," he said.
Seventy per cent of what BioExx will produce from canola meal is contracted for sale to Helm AG, a German company operating in 35 countries around the world. Helm will largely use the protein for aquaculture and baby livestock feeds.
"We reserve 30 per cent of our protein production to sell to other end customers, or work with other, similar companies. There are a number of companies we are in discussion with that will take up the other 30 per cent of our production."
BioExx is also working toward several certifications to allow it to sell proteins into human food markets.
While some market watchers are concerned about the amount of canola available in Western Canada this year due to growing conditions, BioExx is not concerned about its own plant.
"We are a very small processor, and so we use probably less than one per cent of the canola that would be grown in Canada. So from that perspective we don't have a high worry," Carl said.
"Secondly, we have a very good relationship with Viterra, who is the seed supplier. Thirdly, we're using a sort of unique variety of canola that is not necessarily the No. 1 choice of large processors. We're not quite as concerned about getting crowded out from that perspective."
Carl said it's important to point out that while BioExx is doing something different, that doesn't mean it's the only system for all canola processing.
"While we think we have a novel way of doing things, at no time are we suggesting that the way big crushers are doing things is bad.
"What they do at the scale they do it at, they do it in the best possible way as far as we're concerned."
BioExx is publicly traded on the Toronto Stock Exchange under the symbol BXI.
© Copyright (c) The StarPhoenix "
Deren Fazit -sie halten ein EPS von 2CAD innerhalb von 5 Jahren bei 5 voll ausgelasteten Anlagen für möglich -das allerdings bei fast dem 2ppelten an ausstehenden Aktien(!!).
Dazuzusagen ist sicher, dass man das mit Vorsicht geniessen muss -vor allem, da man sich vor dem Hintergrund, dass der CEO gerade noch in dem Zeitungsartikel von vorgestern meinte, dass es noch zu früh für genaue Zahlenkalkulationen wäre, schon fragen muss, worauf die Ihre Annahmen eigentlich aufbauen. Diese Analysten immer.
Aber wie auch immer, ich denke, dass das durchaus mal eine grobe Richtung werden kann, hab mir so ein eigenes Ziel gesetzt, was ich mir hiervon mal erhoffe.